tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2

Alnylam Pharma (0HD2) Similar Shares

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$400.37
$52.92B
1,665.45
67.95%
17 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$100.11
$19.65B
16.79
46.32%
9 Buy
8 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$462.90
$117.45B
32.62
13.24%
16 Buy
6 Hold
0 Sell
Moderate Buy
Argenx Se
$844.92
$52.09B
39.69
34.90%
17 Buy
3 Hold
0 Sell
Strong Buy
Genmab
$33.42
$20.61B
14.08
58.99%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$94.52
$22.73B
-17.05%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0HD2
Alnylam Pharma
400.37
165.51
70.47%
INCY
Incyte
100.11
31.69
46.32%
VRTX
Vertex Pharmaceuticals
462.90
63.55
15.91%
ARGX
Argenx Se
844.92
224.96
36.29%
GMAB
Genmab
33.42
12.65
60.91%
BNTX
BioNTech SE
94.52
-18.06
-16.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts